CRIS Current Research Information System

SANTUCCI, MARIA ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.952
AS - Asia 2.912
EU - Europa 2.344
AF - Africa 171
SA - Sud America 140
Continente sconosciuto - Info sul continente non disponibili 107
OC - Oceania 8
Totale 9.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.885
VN - Vietnam 847
SG - Singapore 806
CN - Cina 717
GB - Regno Unito 615
DE - Germania 320
SE - Svezia 290
IT - Italia 250
UA - Ucraina 194
HK - Hong Kong 146
FR - Francia 143
RU - Federazione Russa 134
IN - India 120
IE - Irlanda 93
BR - Brasile 87
NL - Olanda 87
JP - Giappone 60
TG - Togo 54
ZA - Sudafrica 54
EE - Estonia 42
FI - Finlandia 37
KR - Corea 33
CA - Canada 32
CH - Svizzera 31
JO - Giordania 27
BD - Bangladesh 25
TH - Thailandia 22
BG - Bulgaria 20
MX - Messico 19
SC - Seychelles 19
BE - Belgio 17
AR - Argentina 16
CI - Costa d'Avorio 16
NG - Nigeria 15
ID - Indonesia 13
IR - Iran 13
GR - Grecia 12
PH - Filippine 12
IQ - Iraq 11
EC - Ecuador 10
PL - Polonia 10
VE - Venezuela 10
RO - Romania 9
TW - Taiwan 9
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
TR - Turchia 8
AU - Australia 7
ES - Italia 7
LT - Lituania 7
UZ - Uzbekistan 7
CO - Colombia 6
HR - Croazia 6
PK - Pakistan 6
NP - Nepal 5
AT - Austria 4
CL - Cile 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
MA - Marocco 3
CR - Costa Rica 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
KH - Cambogia 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
PT - Portogallo 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CU - Cuba 1
ET - Etiopia 1
GI - Gibilterra 1
GM - Gambi 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SV - El Salvador 1
VI - Stati Uniti Isole Vergini 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 9.528
Salva come PNG Salva come JPEG
Città #
Singapore 571
Southend 514
Ashburn 402
Chandler 317
Fairfield 315
San Jose 257
Wilmington 173
Seattle 164
Dong Ket 160
Woodbridge 152
Houston 144
Ho Chi Minh City 140
Jacksonville 137
Hong Kong 135
Hanoi 127
Ann Arbor 126
Princeton 123
Council Bluffs 118
Beijing 114
Cambridge 107
Dublin 91
Hefei 88
Santa Clara 80
Boardman 73
Nanjing 60
New York 58
Los Angeles 55
Lomé 54
Westminster 53
Padova 52
Tokyo 49
Lauterbourg 44
Berlin 41
Helsinki 36
Bologna 33
Chicago 33
Frankfurt am Main 32
Bern 28
Buffalo 28
Jinan 28
Amman 26
Seoul 26
Shenyang 24
Da Nang 23
Milan 22
Changsha 20
Medford 20
Mülheim 20
San Diego 20
Sofia 20
Falkenstein 19
Falls Church 19
Hebei 19
Saint Petersburg 18
Phoenix 17
Abidjan 16
Brussels 16
Abeokuta 15
Haiphong 15
Nanchang 15
Redmond 15
Tianjin 15
Verona 15
Guangzhou 13
Taizhou 13
Dallas 12
Des Moines 12
Shanghai 12
Hangzhou 11
London 11
Rome 11
Turin 11
Bengaluru 10
Redondo Beach 10
Bangkok 9
Mahé 9
Montreal 9
São Paulo 9
Toronto 9
Zhengzhou 9
Dearborn 8
Jakarta 8
Kuban 8
Norwalk 8
San Francisco 8
Washington 8
Xi'an 8
Bühl 7
Jiaxing 7
Johannesburg 7
Munich 7
Ningbo 7
Baghdad 6
Bremen 6
Brooklyn 6
Florence 6
Harbin 6
Long Xuyen 6
Nuremberg 6
Portsmouth 6
Totale 6.066
Salva come PNG Salva come JPEG
Nome #
A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib 287
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia 279
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 269
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia. 254
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 243
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 240
Chibby 1: A new component of β-catenin-signaling in chronic myeloid leukemia 230
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 229
14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia 212
Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia 208
CHK2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571 208
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 202
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 202
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl 199
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 196
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 195
Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. 194
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 193
P53 and beta catenin cross-talk in the medulloblastoma cell line radiosensitivity 192
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia 188
C6-Unsubstituted Pyrazolo[3,4-d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines. 188
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 184
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage 183
Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457 182
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 182
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 181
GENOMIC UNBALANCES ASSOCIATED WITH THE RESISTANCE TO IONIZING RADIATIONS OF A HUMAN OSTEOSARCOMA CELL LINE (SAOS) DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION (CGH-BASED TECHNIQUE) 176
The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene 176
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 175
FOXM1 Transcription Factor Is a Component of Beta Catenin Signaling in Hematopoietic Progenitors of Chronic Myeloid Leukemia 171
mTOR inhibitor RAD001 (Everloimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-Abl protein 167
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. 165
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. 165
DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia. 162
IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia 161
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma 160
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells 159
Tyrosine kinase inhibotr STI571 (Imatinib) cooperates with wild type p53 on k562 cell line to enhance its pro-apoptotic effets 158
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein 156
P210 BCR-ABL TYROSINE KINASE INHIBITS APOPTOTIC CELL DEATH THROUGH MULTIPLE PATHWAYS PREVENTING EARLY MITOCHONDRIAL ACTIVATION 152
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 150
New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34(+) cells 149
COVALENT MODIFICATIONS OF HISTONE H4 NH2-TERMINAL TAILS ASSOCIATED WITH P210 BCR-ABL TYROSINE KINASE 148
P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2 147
A new class of dual SRC/ABL kinase inhibitors for the treatment of imatinib-resistant chronic myeloid leukemias 147
Cyclin-dependent kinase 2 (Cdk2) activity at the G1 to S boundary has a role in the resistance of Chronic Myeloid Leukemia (CML) haematopoietic progenitors to the tyrosine kinase inhibitor STI571 (Imatinib) 145
RAD001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia 143
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies 140
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes 136
Idetification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. 126
We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction. 111
La tirosin-cinasi del prodotto p210 di bcr-abl sopprime l'apoptosi mitocondrio dipendente 105
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 84
The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics 78
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3 sigma case. 2
Totale 9.634
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.521
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022814 0 0 0 81 87 58 27 58 31 72 210 190
2022/20231.189 133 205 71 145 82 107 25 51 189 32 85 64
2023/2024304 18 49 16 49 19 79 22 14 8 13 8 9
2024/20251.016 19 149 96 73 181 61 53 62 10 139 15 158
2025/20262.561 217 214 193 164 372 168 214 123 534 211 71 80
2026/2027514 38 88 223 165 0 0 0 0 0 0 0 0
Totale 9.634